A meta-analysis of the effects of vitamin D supplementation on endocrine metabolic and inflammatory markers in patients with polycystic ovarian syndrome
Abstract
Background: To evaluate the effects of vitamin D on the endocrine, metabolic, and inflammatory markers providing new PCOS treatment ideas.
Methods: PubMed, EMBASE, Web of Science, and Cochrane Library were systematically searched for vitamin D treatment studies in PCOS patients from establishment to 12/2022 using vitamin D, polycystic ovary syndrome, PCOS, etc, as search terms. Two researchers independently screened the retrieved literature, extracted the data, and finally performed a meta-analysis of these data with Review Manager 5.4 software to calculate all-parameter weighted mean difference (WMDs) and 95% confidence intervals (CIs) using a fixed-effects or random-effect models.
Results: The 10 included articles mainly studied the effects of vitamin D and placebo control treatment on endocrine, metabolic and inflammatory indicators in PCOS patients. Meta-analysis results showed that compared to placebo, vitamin D reduces the homeostatic model assessment-insulin resistance index (HOMA-IR) (MD = -0.47; 95% CI: -0.66 to -0.28; P .05).
Conclusion: Current evidence indicates that vitamin D supplementation significantly reduced the HOMA-IR, hs-CRP, FBI, and TT in PCOS patients. However, fasting blood glucose (FPG), dehydroepiandrosterone sulfate (DHEAS), free androgen index (FAI), sex hormone-binding globulin (SHBG), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were unaffected.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.